Sectoral Asset Management
JSPR icon

Sectoral Asset Management’s Jasper Therapeutics JSPR Stock Holding History

Sectoral Asset Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,333
Closed -$316K – 126
2022
Q3 		$316K Sell
1,333
-1,052
-44% -$578K 0.06% 98
2022
Q2 		$1.38M Buy
2,385
+135
+6% +$115K 0.28% 85
2022
Q1 		$2.4M Buy
+2,250
New +$3.04M 0.43% 77

Other funds holding JSPR

Qiming U.S. Ventures Management
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
Abingworth
Abingworth London, United Kingdom $304M AUM 95.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Velan Capital Investment Management
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fernwood Investment Management
Fernwood Investment Management Quincy, Massachusetts $288M AUM 33.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Sectoral Asset Management's JSPR Position: Q4 2022 in Review

Sectoral Asset Management sold out of Jasper Therapeutics (JSPR) in Q4 2022, closing a stake of 1,333 shares — an estimated $316K sold.

Sectoral Asset Management first reported a position in JSPR in Q1 2022 and held it in 3 quarters. The position peaked at $2.4M in Q1 2022. 21 funds tracked by Wall St. Rank hold JSPR as of Q4 2022.

  • Sectoral Asset Management reported no remaining Jasper Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Sectoral Asset Management sold 1,333 Jasper Therapeutics shares in Q4 2022, an estimated $316K.
  • Sectoral Asset Management first reported a position in Jasper Therapeutics in Q1 2022 and held it in 3 quarters.
  • Sectoral Asset Management's Jasper Therapeutics position peaked at $2.4M in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q4 2022.

Based on Sectoral Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.